Cargando…

Open treatment of dysplasia—other than PAO: does it have to be a PAO?

Hip dysplasia is a developmental disorder that results in anatomic abnormalities in which the acetabular coverage is insufficient. In the absence of severe degenerative changes, younger active patients with these symptomatic structural abnormalities are increasingly managed with joint-preserving ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Kotaro R., Matsuda, Shuichi, Safran, Marc R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467430/
https://www.ncbi.nlm.nih.gov/pubmed/28630734
http://dx.doi.org/10.1093/jhps/hnv028
_version_ 1783243278655684608
author Shibata, Kotaro R.
Matsuda, Shuichi
Safran, Marc R.
author_facet Shibata, Kotaro R.
Matsuda, Shuichi
Safran, Marc R.
author_sort Shibata, Kotaro R.
collection PubMed
description Hip dysplasia is a developmental disorder that results in anatomic abnormalities in which the acetabular coverage is insufficient. In the absence of severe degenerative changes, younger active patients with these symptomatic structural abnormalities are increasingly managed with joint-preserving operations. Historically there have been numerous reconstructive pelvic osteotomies. In recent years, the Bernese periacetabular osteotomy (PAO) has become the preferred osteotomy by many surgeons. Even so, as our understanding of the hip advances and new diagnostic and treatment techniques are developed, we sought to put a focus on the long-term results of augmental osteotomies and pelvic osteotomies other than the PAO, to see if any of these surgeries still have a place in the current algorithm of treatment for the dysplastic hip. As the longevity of the treatment is the focal point for joint preservation surgeries for the dysplastic hip, these authors have searched databases for articles in the English literature that reported results of long-term follow-up with a minimum of 11-year survivorship after surgical treatment of developmental dysplasia of the hip. Reconstruction osteotomies for the dysplastic hip are intended to restore normal hip anatomy and biomechanics, improve symptoms and prevent degenerative changes, in this manuscript each procedure is independently assessed on the ability to achieve these important characteristics.
format Online
Article
Text
id pubmed-5467430
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-54674302017-06-19 Open treatment of dysplasia—other than PAO: does it have to be a PAO? Shibata, Kotaro R. Matsuda, Shuichi Safran, Marc R. J Hip Preserv Surg Review Articles Hip dysplasia is a developmental disorder that results in anatomic abnormalities in which the acetabular coverage is insufficient. In the absence of severe degenerative changes, younger active patients with these symptomatic structural abnormalities are increasingly managed with joint-preserving operations. Historically there have been numerous reconstructive pelvic osteotomies. In recent years, the Bernese periacetabular osteotomy (PAO) has become the preferred osteotomy by many surgeons. Even so, as our understanding of the hip advances and new diagnostic and treatment techniques are developed, we sought to put a focus on the long-term results of augmental osteotomies and pelvic osteotomies other than the PAO, to see if any of these surgeries still have a place in the current algorithm of treatment for the dysplastic hip. As the longevity of the treatment is the focal point for joint preservation surgeries for the dysplastic hip, these authors have searched databases for articles in the English literature that reported results of long-term follow-up with a minimum of 11-year survivorship after surgical treatment of developmental dysplasia of the hip. Reconstruction osteotomies for the dysplastic hip are intended to restore normal hip anatomy and biomechanics, improve symptoms and prevent degenerative changes, in this manuscript each procedure is independently assessed on the ability to achieve these important characteristics. Oxford University Press 2015-05-13 /pmc/articles/PMC5467430/ /pubmed/28630734 http://dx.doi.org/10.1093/jhps/hnv028 Text en © The Author 2015. Published by Oxford University Press http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Shibata, Kotaro R.
Matsuda, Shuichi
Safran, Marc R.
Open treatment of dysplasia—other than PAO: does it have to be a PAO?
title Open treatment of dysplasia—other than PAO: does it have to be a PAO?
title_full Open treatment of dysplasia—other than PAO: does it have to be a PAO?
title_fullStr Open treatment of dysplasia—other than PAO: does it have to be a PAO?
title_full_unstemmed Open treatment of dysplasia—other than PAO: does it have to be a PAO?
title_short Open treatment of dysplasia—other than PAO: does it have to be a PAO?
title_sort open treatment of dysplasia—other than pao: does it have to be a pao?
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467430/
https://www.ncbi.nlm.nih.gov/pubmed/28630734
http://dx.doi.org/10.1093/jhps/hnv028
work_keys_str_mv AT shibatakotaror opentreatmentofdysplasiaotherthanpaodoesithavetobeapao
AT matsudashuichi opentreatmentofdysplasiaotherthanpaodoesithavetobeapao
AT safranmarcr opentreatmentofdysplasiaotherthanpaodoesithavetobeapao